Table 3 Significant association between TFPI single nucleotide polymorphisms (SNPs) and clinicopathological characteristics and molecular subtypes

T status

T1

Reference

Reference

Reference

Reference

T2 to T3

rs10153820

A

3.14

1.44, 6.86

0.004

0.056

TN status (ER-/PR-/HER2-negative)

No

Reference

Reference

Reference

Reference

Yes

rs8176541^a

G

2.62

1.11, 5.35

0.026

0.092

rs3213739^a

G

2.58

1.34, 4.99

0.005

0.033

rs8176479^a

C

3.10

1.24, 7.72

0.015

0.071

rs2192824^a

T

2.44

1.39, 4.93

0.002

0.033

N status

Positive

Reference

Reference

Reference

Reference

Negative

rs10179730

G

3.34

1.42, 7.89

0.006

0.083

Basal tumor subtype

Non-basal

Reference

Reference

Reference

Reference

Basal

rs3213739^a

G

2.23

1.15, 4.34

0.018

0.107

rs8176479^a

C

2.79

1.12, 6.96

0.028

0.107

rs2192824^a

T

2.41

1.24, 4.65

0.009

0.107

rs10187622^a

C

5.20

1.17, 23.20

0.031

0.107

Luminal B tumor subtype

Non-luminal B

Reference

Reference

Reference

Reference

Luminal B

rs16829086^a

T

2.09

1.03, 4.25

0.041

0.191

rs10179730^a

G

3.53

1.47, 8.46

0.005

0.066

rs10187622^a

T

2.73

1.24, 6.03

0.013

0.091

Normal-like tumor subtype

Non-normal-like

Reference

Reference

Reference

Reference

Normal-like

rs5940

T

22.17

4.43, 110.8

0.0002

0.003